IFP Advisors, Inc. has filed a Form 13F-HR disclosing its equity holdings as of September 30, 2026. The filing lists Christopher Marcellus Brooks as the Director of Supervision responsible for the report.
The portfolio includes a diverse range of common stock positions. Notable holdings include shares of Advanced Micro Devices Inc., Alphabet Inc., Abbott Laboratories, and AbbVie Inc. The firm also holds significant positions in exchange-traded funds, including various trusts and funds managed by ABRDN and AIM ETF Products Trust.
The filing details specific share counts for numerous companies, such as 48,708,331 shares of Advanced Micro Devices Inc., 64,976,733 shares of Alphabet Inc., and 27,281,330 shares of Abbott Laboratories. Additionally, the report lists smaller positions in companies including Aardvark Therapeutics Inc., A10 Networks Inc., and Acacia Resh Corp.
